Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome †

Hepatology - Tập 28 Số 3 - Trang 638-645 - 1998
Russell H. Wiesner1, Jake Demetris2, Steven H. Belle2, Eric C. Seaberg2, John R. Lake3, Rowen K. Zetterman4, James E. Everhart5, Katherine M. Detre2
1Mayo Clinic and Foundation, Rochester, MN
2University of Pittsburgh
3Univ. of California San Francisco, CA
4University of Nebraska Medical Center, Omaha, NE
5NATIONAL INSTITUTES OF HEALTH

Tóm tắt

Hepatic allograft rejection remains an important problem following liver transplantation, and, indeed, complications related to the administration of immunosuppressive therapy remain a predominant cause of posttransplantation morbidity and mortality. The Liver Transplantation Database (LTD) was used to study a cohort of 762 consecutive adult liver transplantation recipients and determined the incidence, timing, and risk factors for acute rejection. We also evaluated the impact of histological severity of rejection on the need for additional immunosuppressive therapy and on patient and graft survival. Four hundred ninety (64%) of the 762 adult liver transplantation recipients developed at least one episode of rejection during a median follow-up period of 1,042 days (range, 336-1,896 days), most of which occurred during the first 6 weeks after transplantation. Multivariate analysis revealed that recipient age, serum creatinine, aspartate transaminase (AST) level, presence of edema, donor/recipient HLA-DR mismatch, cold ischemic time, and donor age were independently associated with the time to acute rejection. An interesting observation was that the histological severity of rejection was an important prognosticator: the use of antilymphocyte preparations was higher, and the time to death or retransplantation was shorter, for patients with severe rejection. Findings from this study will assist in decision-making for the use of immunosuppressive regimens and call into question whether complete elimination of all rejection or alloreactivity is a desirable goal in liver transplantation.

Từ khóa


Tài liệu tham khảo

An update in liver transplantation in the United States: recipient characteristics and outcome. In: eds. Clinical Transplants 1995. Los Angeles: UCLA Tissue Typing Laboratories, 1996;19-33.

Asfar, 1996, Transplantation, 61, 1377, 10.1097/00007890-199605150-00016

Wiesner, 1991, Hepatology, 14, 721, 10.1002/hep.1840140424

1994, N Engl J Med, 331, 1110, 10.1056/NEJM199410273311702

Klintmalm, 1989, Hepatology, 10, 978, 10.1002/hep.1840100615

Datta-Gupta, 1995, Hepatology, 21, 46, 10.1002/hep.1840210110

Demetris, 1991, Hepatology, 14, 751, 10.1002/hep.1840140502

1995, Hepatology, 22, 648

Demetris, 1995, Hepatology, 21, 408, 10.1002/hep.1840210223

Wei, 1997, for the NIDDK Liver Transplantation Database Liver Transplantation and Surgery, 3, 10, 10.1002/lt.500030102

Demetris, 1997, Hepatology, 25, 658, 10.1002/hep.510250328

Wiesner, 1996, Liver Transplantation and Surgery, 2, 165, 10.1002/lt.500020214

Millis, 1996, Transplantation, 61, 1365, 10.1097/00007890-199605150-00014

Klintmalm, 1993, Transplant Proc, 25, 679

McDiarmid, 1993, Transpl Int, 6, 305, 10.1111/j.1432-2277.1993.tb00672.x

Klintmalm, 1993, Transplant Proc, 25, 697

Kaplan, 1958, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452

The statistical analysis of failure time data. New York: John Wiley and Sons, 1980.

Cox, 1972, J Royal Stat Soc B, 34, 187, 10.1111/j.2517-6161.1972.tb00899.x

Nonparametric Statistical Methods. New York: John Wiley and Sons, 1973.

Categorical Data Analysis. New York: John Wiley and Sons, 1990.

Mantel, 1974, J Am Stat Assoc, 69, 81, 10.1080/01621459.1974.10480131

1994, Lancet, 344, 423, 10.1016/S0140-6736(94)91766-3

Farges, 1996, Hepatology, 23, 240, 10.1002/hep.510230207

Berlakovich, 1996, Transplantation, 61, 554, 10.1097/00007890-199602270-00007

Adams, 1991, Transplant Proc, 23, 1436

Gish, 1995, J Hepatol, 22, 257, 10.1016/0168-8278(95)80276-2

Rimola, 1987, Gastroenterology, 93, 148, 10.1016/0016-5085(87)90327-1

Gonwa, 1995, Transplantation, 59, 361, 10.1097/00007890-199502150-00010

Nikaein, 1994, Transplantation, 58, 786, 10.1097/00007890-199410150-00006

Pirsch, 1992, Transplantation, 53, 55, 10.1097/00007890-199201000-00010

Gomez, 1995, Rev Esp Enferm Dig, 87, 217

Kiuchi, 1995, Transplantation, 60, 49, 10.1097/00007890-199507150-00010

Yersiz, 1995, Transplantation, 60, 790, 10.1097/00007890-199510270-00005

Howard, 1990, Transplantation, 49, 103, 10.1097/00007890-199001000-00023

Terasaki, 1995, N Engl J Med, 333, 333, 10.1056/NEJM199508103330601

Makinodan, 1980, Adv Immunol, 29, 287, 10.1016/S0065-2776(08)60047-4

Lindholm, 1993, Transplantation, 56, 307, 10.1097/00007890-199308000-00010

Tesi, 1993, Clin Transplant, 7, 345, 10.1111/j.1399-0012.1993.tb00929.x

et al. The role of passenger leukocytes in rejection and ?tolerance? after solid organ transplantation: a potential explanation of a paradox. In: ed. Rejection and Tolerance. Dordrecht, the Netherlands: Kluwer Academic Publishers, 1994;325-392.

Farges, 1995, Transpl Proc, 27, 1142